These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6223236)

  • 1. Effect of cholinergic agents in Huntington's disease: a reappraisal.
    Nutt JG
    Neurology; 1983 Jul; 33(7):932-5. PubMed ID: 6223236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central cholinergic-anticholinergic antagonism in Huntington's chorea.
    Klawans HL; Rubovits R
    Neurology; 1972 Feb; 22(2):107-16. PubMed ID: 4257815
    [No Abstract]   [Full Text] [Related]  

  • 3. A physiologic and pharmacologic study in anticholinergic-responsive essential myoclonus.
    Chokroverty S; Manocha MK; Duvoisin RC
    Neurology; 1987 Apr; 37(4):608-15. PubMed ID: 3561772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deanol acetamidobenzoate treatment in choreiform movement disorders.
    Tarsy D; Bralower M
    Arch Neurol; 1977 Dec; 34(12):756-8. PubMed ID: 145212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meige syndrome: relief on high-dose anticholinergic therapy.
    Duvoisin RC
    Clin Neuropharmacol; 1983 Mar; 6(1):63-6. PubMed ID: 6850651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of cholinergic drug effects on memory in Alzheimer's disease.
    Brinkman SD; Gershon S
    Neurobiol Aging; 1983; 4(2):139-45. PubMed ID: 6355883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential myoclonus: response to anticholinergic therapy.
    Duvoisin RC
    Clin Neuropharmacol; 1984; 7(2):141-7. PubMed ID: 6733693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Huntington disease with a cholinergic agonist.
    Nutt JG; Rosin A; Chase TN
    Neurology; 1978 Oct; 28(10):1061-4. PubMed ID: 154624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of scopolamine in Huntington's disease.
    Nutt JG; Morgan NT
    Adv Neurol; 1983; 37():291-7. PubMed ID: 6222635
    [No Abstract]   [Full Text] [Related]  

  • 10. Progress in understanding Huntington's chorea.
    Barbeau A
    Can J Neurol Sci; 1975 May; 2(2):81-5. PubMed ID: 124199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New attempt at treating Huntington's chorea (preliminary report)].
    Domzal T
    Neurol Neurochir Pol; 1976; 10(1):45-8. PubMed ID: 130561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethyl aminoethanol in Huntington's chorea.
    Walker JE; Hoehn M; Sears E; Lewis J
    Lancet; 1973 Jun; 1(7818):1512-3. PubMed ID: 4123177
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholinergic approaches to the treatment of Alzheimer's disease.
    Hollander E; Mohs RC; Davis KL
    Br Med Bull; 1986 Jan; 42(1):97-100. PubMed ID: 3006861
    [No Abstract]   [Full Text] [Related]  

  • 14. Physostigmine reversal of scopolamine-induced hypofrontality.
    Prohovnik I; Arnold SE; Smith G; Lucas LR
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):220-8. PubMed ID: 9040502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modern methods of treating Huntington's chorea].
    Kuran W
    Pol Tyg Lek; 1976 Aug; 31(32):1409-11. PubMed ID: 135971
    [No Abstract]   [Full Text] [Related]  

  • 16. Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs.
    Granacher RP; Baldessarini RJ
    Arch Gen Psychiatry; 1975 Mar; 32(3):375-80. PubMed ID: 1115577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethopropazine and benztropine in neuroleptic-induced parkinsonism.
    Chouinard G; Annable L; Ross-Chouinard A; Kropsky ML
    J Clin Psychiatry; 1979 Mar; 40(3):147-52. PubMed ID: 33969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of extrapyramidal side effects induced by neuroleptics.
    Tune LE; McHugh PR; Coyle JT
    Johns Hopkins Med J; 1981 Mar; 148(3):149-53. PubMed ID: 7206408
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined use of tertiary amine parasympathomimetics with a quaternary amine parasympatholitic--a new perspective to use parasympathomimetic drugs for systemic analgesia.
    Tekol Y; Eminel S
    Pharmazie; 2002 Jul; 57(7):485-6. PubMed ID: 12168532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.